Varex Imaging Corporation (VREX) P/E Ratio History
Historical price-to-earnings valuation from 2017 to 2024
Loading P/E history...
VREX Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Varex Imaging Corporation (VREX) trades at a price-to-earnings ratio of -5.8x, with a stock price of $9.83 and trailing twelve-month earnings per share of $-1.97.
The current P/E is 110% below its 5-year average of 58.1x. Over the past five years, VREX's P/E has ranged from a low of 19.0x to a high of 229.3x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.2x, VREX trades at a 126% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 176.0x.
Relative to the broader market, VREX trades at a notable discount to the S&P 500 median P/E of 24.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our VREX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
VREX P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $17B | 30.5 | - | -25% | |
| $160B | 57.2 | 2.63 | +23% | |
| $4B | 86.6 | 57.98 | +104% | |
| $310B | 36.4 | 3.08 | +36% | |
| $29B | 13.9Lowest | - | +5% | |
| $109B | 34.0 | 2.29Best | +8% | |
| $26B | 24.9 | - | +224%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
VREX Historical P/E Data (2017–2024)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q3 | Fri Jun 28 2024 00:00:00 GM | $14.73 | $0.69 | 21.5x | -58% |
| FY2024 Q2 | Fri Mar 29 2024 00:00:00 GM | $18.10 | $0.83 | 21.8x | -58% |
| FY2024 Q1 | Fri Dec 29 2023 00:00:00 GM | $20.50 | $0.90 | 22.8x | -56% |
| FY2023 Q4 | Sat Sep 30 2023 00:00:00 GM | $18.79 | $0.99 | 19.0x | -63% |
| FY2023 Q3 | Fri Jun 30 2023 00:00:00 GM | $23.57 | $0.68 | 34.8x | -32% |
| FY2023 Q2 | Fri Mar 31 2023 00:00:00 GM | $18.19 | $0.70 | 26.1x | -49% |
| FY2023 Q1 | Fri Dec 30 2022 00:00:00 GM | $20.30 | $0.78 | 26.1x | -49% |
| FY2022 Q4 | Fri Sep 30 2022 00:00:00 GM | $21.14 | $0.73 | 29.0x | -44% |
| FY2022 Q3 | Fri Jul 01 2022 00:00:00 GM | $21.33 | $0.61 | 35.0x | -32% |
| FY2022 Q2 | Fri Apr 01 2022 00:00:00 GM | $21.33 | $0.70 | 30.5x | -41% |
| FY2022 Q1 | Fri Dec 31 2021 00:00:00 GM | $31.55 | $0.60 | 52.6x | +2% |
| FY2021 Q4 | $28.20 | $0.41 | 68.8x | +34% |
Average P/E for displayed period: 51.3x
See VREX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VREX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VREX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVREX — Frequently Asked Questions
Quick answers to the most common questions about buying VREX stock.
Is VREX stock overvalued or undervalued?
VREX trades at -5.8x P/E, below its 5-year average of 58.1x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does VREX's valuation compare to peers?
Varex Imaging Corporation P/E of -5.8x compares to sector median of 22.2x. The discount suggests lower growth expectations or higher risk.
What is VREX's PEG ratio?
VREX PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2017-2024.